Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $75000.0.

  • Silence Therapeutics' Amortizatization of Intangibles rose 62154.22% to $75000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $271000.0, marking a year-over-year increase of 17959.83%. This contributed to the annual value of $257000.0 for FY2024, which is 198.41% up from last year.
  • Latest data reveals that Silence Therapeutics reported Amortizatization of Intangibles of $75000.0 as of Q3 2025, which was up 62154.22% from $67000.0 recorded in Q2 2025.
  • Silence Therapeutics' 5-year Amortizatization of Intangibles high stood at $75000.0 for Q3 2025, and its period low was $1178.5 during Q3 2022.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $10782.4 (2023), whereas its average is $23800.5.
  • Per our database at Business Quant, Silence Therapeutics' Amortizatization of Intangibles tumbled by 8053.79% in 2022 and then soared by 134936.93% in 2023.
  • Over the past 5 years, Silence Therapeutics' Amortizatization of Intangibles (Quarter) stood at $2696.0 in 2021, then tumbled by 56.29% to $1178.5 in 2022, then skyrocketed by 847.81% to $11170.4 in 2023, then surged by 472.94% to $64000.0 in 2024, then increased by 17.19% to $75000.0 in 2025.
  • Its last three reported values are $75000.0 in Q3 2025, $67000.0 for Q2 2025, and $65000.0 during Q1 2025.